Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Mawson Infrastructure Group Inc.Financial_Report.xls

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 10-Q/A

(Mark One)


  X .

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


For the quarterly period ended June 30, 2012


or


      .

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934


For the transition period from _______________________to___________________________


Commission File Number: 000-52545


OPHTHALIX INC.

(Exact name of registrant as specified in its charter)


Delaware

88-0445167

(State or other jurisdiction of incorporation or organization)

(I.R.S. Employer Identification No.)

 

 

1656 Reunion Avenue, Suite 250, South Jordan, UT

84095

(Address of principal executive offices)

(Zip Code)

 

 

+(972) 36133372

(Registrant’s telephone number, including area code)


Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  X  . No      .


Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes  X . No      .


Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.


Large accelerated filer

      .

Accelerated filer

      .

Non-accelerated filer

      . (Do not check if a smaller reporting company)

Smaller reporting company

  X .


Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes      . No  X  .


The number of shares outstanding of the registrant’s common stock on August 9, 2012, was 46,985,517.




EXPLANATORY NOTE


The purpose of this Amendment No. 1 to the Quarterly Report of OphthaliX Inc. on Form 10-Q for the quarterly period ended June 30, 2012, filed with the Securities and Exchange Commission on August 13, 2012 (the “Form 10-Q”), is solely to furnish Exhibit 101 to the Form 10-Q in accordance with Rule 405 of Regulation S-T.  Exhibit 101 to this report provides the consolidated financial statements and related notes from the Form 10-Q formatted in XBRL (eXtensible Business Reporting Language).  As permitted by Rule 405(a)(2)(ii) of Regulation S-T, Exhibit 101 is required to be furnished by amendment within 30 days of the original filing date of the Form 10-Q.


No other changes have been made to the Form 10-Q.  This Amendment No. 1 to the Form 10-Q speaks as of the original filing date of the Form 10-Q, does not reflect events that may have occurred subsequent to the original filing date, and does not modify or update in any way disclosures made in the original Form 10-Q.


Pursuant to Rule 406T of Regulation S-T, the interactive data files on Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise are not subject to liability under those sections.





PART II.  OTHER INFORMATION


Item 6. Exhibits


The Exhibits filed as part of this amended report are listed on the Exhibit Index immediately following the signature page hereto, which Exhibit Index is incorporated herein by reference.



SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


OphthaliX Inc.



Date: August 29, 2012

By /s/ Pnina Fishman                                        

      Pnina Fishman, Chief Executive Officer (Principal Executive Officer)




Date: August 29, 2012

By /s/ Itay Weinstein                                         

      Itay Weinstein, Chief Financial Officer  (Principal Financial Officer)





EXHIBIT INDEX


Exhibit No.

Description


31.1

Rule 15d-14(a) Certification by Principal Executive Officer(1)


31.2

Rule 15d-14(a) Certification by Principal Financial Officer(1)


32.1

Section 1350 Certification of Principal Executive Officer(1)


32.2

Section 1350 Certification of Principal Financial Officer(1)


101.

INS

XBRL Instance Document


101.

SCH

XBRL Taxonomy Extension Schema Document


101.

CAL

XBRL Taxonomy Extension Calculation Linkbase Document


101.

DEF

XBRL Taxonomy Extension Definition Linkbase Document


101.

LAB

XBRL Taxonomy Extension Label Linkbase Document


101.

PRE

XBRL Taxonomy Extension Presentation Linkbase Document

___________________

(1) These exhibits were previously included in the Quarterly Report of OphthaliX Inc. on Form 10-Q for the quarterly period ended June 30, 2012, filed with the Securities and Exchange Commission on August 13, 2012.